Potential risk of myopathy by HMG-CoA reductase inhibitors: a comparison of pravastatin and simvastatin effects on membrane electrical properties of rat skeletal muscle fibers.

Pierno, S; De Luca, A; Tricarico, D; Roselli, A; Natuzzi, F; Ferrannini, E; Laico, M; Camerino, D C

Pierno, S; De Luca, A; Tricarico, D; Roselli, A; Natuzzi, F; Ferrannini, E; Laico, M; Camerino, D C.

Affiliation

Pierno S; Department of Pharmacobiology, Faculty of Pharmacy, University of Bari, Italy.

J Pharmacol Exp Ther ; 275(3): 1490-6, 1995 Dec.

Article in En | MEDLINE | ID: mdl-8531120

Subject(s)

Enzyme Inhibitors/pharmacology; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin/analogs & derivatives; Muscle, Skeletal/drug effects; Pravastatin/pharmacology; Animals; In Vitro Techniques; Lovastatin/pharmacology; Male; Membrane Potentials/drug effects; Muscle, Skeletal/physiology; Rats; Rats, Wistar; Simvastatin

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Lovastatin / Pravastatin / Muscle, Skeletal / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Enzyme Inhibitors Type of study: Etiology_studies / Risk_factors_studies Limits: Animals Language: En Journal: J Pharmacol Exp Ther Year: 1995 Document type: Article Affiliation country: Italy Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links